WONBIOGEN CO., LTD. Wonbiogen Co., Ltd. Share Price
Equities
A307280
KR7307280008
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,840 KRW | +0.05% |
|
+2.28% | +8.11% |
| 2023 | Wonbiogen Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
| 2022 | Tranche Update on Wonbiogen Co., Ltd.'s Equity Buyback Plan announced on May 16, 2022. | CI |
| Sales 2022 | 26.75B 19.53M 1.56B | Sales 2023 | 29.61B 21.62M 1.73B | Capitalization | 60.37B 44.07M 3.53B |
|---|---|---|---|---|---|
| Net income 2022 | 3.21B 2.34M 187M | Net income 2023 | 5.5B 4.01M 321M | EV / Sales 2022 | 2.21 x |
| Net Debt 2022 | 628M 459K 36.69M | Net cash position 2023 | 1.24B 904K 72.31M | EV / Sales 2023 | 2 x |
| P/E ratio 2022 |
18.8
x | P/E ratio 2023 |
11.7
x | Employees | - |
| Yield 2022 |
0.6% | Yield 2023 |
1.18% | Free-Float | 64.93% |
More Fundamentals
* Assessed data
More news
| 1 day | +0.05% | ||
| 1 week | +2.28% | ||
| Current month | -0.59% | ||
| 1 month | -0.59% | ||
| 3 months | +14.43% | ||
| 6 months | +18.63% | ||
| Current year | +8.11% |
1 week
1 780.00
1 879.00
1 month
1 721.001 900.00
Current year
1 550.001 990.00
1 year
1 473.002 635.00
3 years
1 230.003 080.00
5 years
1 230.004 245.00
10 years
1 230.004 245.00
| Managers | Title | Age | Since |
|---|---|---|---|
Won-Il Kim
CEO | Chief Executive Officer | 48 | 22/01/21 |
Hyun-Kang Shin
AUD | Comptroller/Controller/Auditor | 64 | 28/02/17 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Yoon-Seok Choi
BRD | Director/Board Member | 47 | - |
Won-Il Kim
CEO | Chief Executive Officer | 48 | 22/01/21 |
Jong-Min Lee
BRD | Director/Board Member | 47 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/05/24 | 1,845 | +0.27% | 76,390 |
| 30/04/24 | 1,840 | +0.05% | 198,450 |
| 29/04/24 | 1,839 | +0.99% | 124,397 |
| 26/04/24 | 1,821 | +1.51% | 235,041 |
| 25/04/24 | 1,794 | -1.16% | 99,990 |
End-of-day quote Korea S.E., April 29, 2024
More quotes
Wonbiogen Co Ltd, formerly Kyobo 8 Special Purpose Acquisition Co, is a Korea-based company engaged in the manufacturing and sale of medical supplies. The Company provides medical products including dressing material used for lower leg ulcers, pressure ulcers and surgical wounds; dressing material for secretions absorption and wound area protection; fixing band for bandages, gauze, catheters, along with others.
Calendar
12/05/2024
- Q1 2024 Earnings Release (Projected)
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +8.11% | 47.17M | |
| +8.96% | 26.92B | |
| -31.01% | 3.12B | |
| -15.97% | 2.52B | |
| +18.11% | 2.47B | |
| +3.70% | 2B | |
| -9.47% | 1.91B | |
| -2.22% | 1.48B | |
| +2.24% | 1.31B | |
| +18.92% | 1.18B |
- Stock Market
- Equities
- A307280 Stock
